Coronavirus (COVID-19)
Learn more
April 10, 2017
Sponsor: National Surgical Adjuvant Breast and Bowel Project (NSABP)
Number: B-51
Eligible patients who enroll in the study will be randomly assigned (by chance) to this phase III trial (Phase III trials are new treatments that have worked well in a small number of patients with this disease). This trial studies standard or comprehensive radiation therapy in treating patients with early-stage breast cancer who have already undergone surgery. Radiation therapy uses high-energy x rays to kill tumor cells. It is not yet known whether comprehensive radiation therapy is more effective than standard radiation therapy in treating patients with breast cancer.
Who’s eligible:
Available at: The Hospital of Central Connecticut, MidState Medical Center, and Hartford Hospital.
Referral Line: 860.972.4700
Get the latest healthcare news directly in your inbox.
Sign up for text alerts / Text MoreLife to 31996.